Regentis Biomaterials (RGNT) Preferred Stock Liabilities (2024)
Regentis Biomaterials (RGNT) reported Preferred Stock Liabilities of $35.1 million for Q4 2024.
Regentis Biomaterials (RGNT) Preferred Stock Liabilities (2024) Analysis & Trends
Regentis Biomaterials (RGNT) has 1 years of Preferred Stock Liabilities data on file, last reported at $35.1 million in Q4 2024.
- Preferred Stock Liabilities for Q4 2024 came in at $35.1 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2024 was $35.1 million (changed N/A YoY), and the FY2024 annual result was $35.1 million, changed N/A from the prior year.
- Preferred Stock Liabilities steadied at $35.1 million in Q4 2024 per RGNT's latest filing.
- Over five years, Preferred Stock Liabilities peaked at $35.1 million in Q4 2024 and troughed at $35.1 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | - |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | - |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | - |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | - |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | - |
| 10 | Regentis Biomaterials | 3.72 Mn | -3.66 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 35.10 Mn |